Thomas Nathaniel to Middle Aged
This is a "connection" page, showing publications Thomas Nathaniel has written about Middle Aged.
Connection Strength
0.933
-
Clinical Risk Factors Associated with Ambulatory Outcome in Acute Ischemic Stroke Patient Smokers Treated with Thrombolytic Therapy. Am J Med Sci. 2021 10; 362(4):363-374.
Score: 0.054
-
Gender differences in comorbidities and risk factors in ischemic stroke patients with a history of atrial fibrillation. BMC Neurol. 2021 May 25; 21(1):209.
Score: 0.054
-
Comorbidities associated with different levels of total cholesterol in male and female acute ischemic stroke patients. Medicine (Baltimore). 2020 Dec 24; 99(52):e23870.
Score: 0.053
-
Thrombolytic therapy in ischemic stroke patients with pre-stroke depression in the telestroke vs non-telestroke. J Stroke Cerebrovasc Dis. 2020 Sep; 29(9):104890.
Score: 0.051
-
Ischemic stroke with a preceding Trans ischemic attack (TIA) less than 24 hours and thrombolytic therapy. BMC Neurol. 2020 May 19; 20(1):197.
Score: 0.051
-
Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients. Lipids Health Dis. 2020 May 06; 19(1):84.
Score: 0.051
-
The Association Between an Antecedent of Transient Ischemic Attack Prior to Onset of Stroke and Functional Ambulatory Outcome. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620906867.
Score: 0.049
-
In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy? Womens Health (Lond). 2020 Jan-Dec; 16:1745506520922760.
Score: 0.049
-
Gender and thrombolysis therapy in acute ischemic stroke patients with incidence of obesity. Neurol Sci. 2019 Sep; 40(9):1829-1839.
Score: 0.047
-
Effect of antihypertensive medications on thrombolysis therapy and outcomes in acute ischemic stroke patients. J Clin Hypertens (Greenwich). 2019 02; 21(2):271-279.
Score: 0.046
-
Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia. BMC Womens Health. 2019 01 16; 19(1):11.
Score: 0.046
-
Thrombolysis Therapy in Specialized and Non-specialized Stroke Units. Arch Med Res. 2018 11; 49(8):588-597.
Score: 0.046
-
Predictors of thrombolysis in the telestroke and non telestroke settings for hypertensive acute ischemic stroke patients. BMC Neurol. 2018 Dec 21; 18(1):215.
Score: 0.046
-
Stroke and dyslipidemia: clinical risk factors in the telestroke versus non-telestroke. Lipids Health Dis. 2018 Sep 27; 17(1):226.
Score: 0.045
-
Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke. J Stroke Cerebrovasc Dis. 2018 Sep; 27(9):2524-2533.
Score: 0.044
-
In a stroke cohort with incident hypertension; are more women than men likely to be excluded from recombinant tissue-type Plasminogen Activator (rtPA)? J Neurol Sci. 2018 04 15; 387:139-146.
Score: 0.043
-
Pharmacological thrombolysis for acute ischemic stroke treatment: Gender differences in clinical risk factors. Adv Med Sci. 2018 Mar; 63(1):100-106.
Score: 0.042
-
Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator. J Stroke Cerebrovasc Dis. 2016 Nov; 25(11):2569-2574.
Score: 0.039
-
Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke. Brain Inj. 2016; 30(10):1261-5.
Score: 0.039
-
Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation. Restor Neurol Neurosci. 2015; 33(3):301-8.
Score: 0.035